Summary

● The company usually posts poor financials for mid or long term investments.


Strengths

● The company shows low valuation levels, with an enterprise value at 0.8 times its sales.

● Sales forecast by analysts have been recently revised upwards.


Weaknesses

● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company has insufficient levels of profitability.

● One of the major weak points of the company is its financial situation.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The group usually releases earnings worse than estimated.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Most analysts recommend that the stock should be sold or reduced.

● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.

● The underlying tendency is negative on the weekly chart below the resistance at 32.38 EUR